Search Results - Alberto Pagani

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation

    Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation by Nieves Márquez, Marco A. Calzado, Gonzalo Sánchez‐Duffhues, Moisés Pérez, Alberto Minassi, Alberto Pagani, Giovanni Appendino, Laura Díaz, María Ángeles Muñoz‐Fernández, Eduardo Muñóz

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?

    What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? by Sandra Maria Barbalho, Júlia Novaes Matias, Uri Adrian Prync Flato, João Paulo Galletti Pilon, Piero Bitelli, Marcos Alberto Pagani, Antonelly Cassio Alves de Carvalho, Jesselina Francisco dos Santos Haber, Carlos Henrique Bertoni Reis, Ricardo de Álvares Goulart

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Incidence of Bacteriobilia and the Correlation with Antibioticoprophylaxis in Low-Risk Patients Submitted to Elective Videolaparoscopic Cholecystectomy: A Randomized Clinical Trial

    Incidence of Bacteriobilia and the Correlation with Antibioticoprophylaxis in Low-Risk Patients Submitted to Elective Videolaparoscopic Cholecystectomy: A Randomized Clinical Trial by Marcos Alberto Pagani, Pedro Meira Dolfini, Beatriz Flávia de Moraes Trazzi, Maria Ines Meira Dolfini, William Saranholi da Silva, Eduardo Federighi Baisi Chagas, Carlos Henrique Bertoni Reis, João Paulo Galletti Pilon, Bruna Trazzi Pagani, Rodrigo Tavore Strasser, Claudemir Gregório Mendes, Fausto Tucunduva Vernaschi, Daniela Vieira Buchaim, Rogério Leone Buchaim

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade

    Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade by Jason K. Cullen, Pei-Yi Yap, Blake Ferguson, Zara C. Bruce, Motoko Koyama, Herlina Y. Handoko, Kevin Hendrawan, Jacinta L. Simmons, Kelly Brooks, Jenny Johns, Emily Wilson, Marjorie M. A. de Souza, Natasa Broit, Praphaporn Stewart, Daniel J. Shelley, Tracey R. McMahon, Steven M. Ogbourne, Tam H. Nguyen, Yi Chieh Lim, Alberto Pagani, Giovanni Appendino, Victoria Gordon, Paul Reddell, Glen M. Boyle, Peter G. Parsons

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: